Pharmacotherapy of depression in oldage

被引:0
|
作者
Hegerl, U [1 ]
Möller, HJ [1 ]
机构
[1] Univ Munich, Psychiat Klin, Abt Klin Neurophysiol, D-80336 Munich, Germany
来源
NERVENARZT | 2000年 / 71卷 / 01期
关键词
depression; antidepressants; older age; SSRI; comorbidity;
D O I
10.1007/s001150050001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Antidepressants are not only effective in younger adults but also in older persons with depression. However there a re pecularities, which have to be taken into account when treating older patients. The enhanced risk of side effects has to be balanced with the more serious consequences of an untreated depression in old age. The efficacy in older patients has been proven not only for tricyclic antidepressants but also for SSRI and other newer antidepressants. The easy handling, the side effect profile and the safety in overdose are advantages of SSRI and newer antidepressants, which become particularly important in old age. The advantages and disadvantages of different classes of antidepressants with regard to comorbidity and comedication are discussed. In older subjects, changes of dosage should be slower and for some, but not for all antidepressants, dosage should be lower.
引用
收藏
页码:1 / 8
页数:10
相关论文
共 50 条
  • [31] Evidence-based pharmacotherapy of treatment-resistant unipolar depression
    Dold, Markus
    Kasper, Siegfried
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2017, 21 (01) : 13 - 23
  • [32] Recent Developments in Pharmacotherapy of Depression: Bench to Bedside
    Shad, Mujeeb U.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [33] Psychosocial and clinical predictors of response to pharmacotherapy for depression
    Bagby, RM
    Ryder, AG
    Cristi, C
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2002, 27 (04): : 250 - 257
  • [34] Acute Pharmacotherapy for Anxiety Symptoms in Patients with Depression
    Quante, A.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2015, 83 (03) : 142 - 148
  • [35] Pharmacotherapy for Depression and Anxiety in the Primary Care Setting
    Parish, Abby Luck
    Gillis, Brenna
    Anthamatten, Angelina
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2023, 19 (04):
  • [36] THE COMBINATION OF PSYCHOTHERAPY AND PHARMACOTHERAPY IN THE TREATMENT OF ADULT DEPRESSION: A COMPREHENSIVE META-ANALYSIS
    Cuijpers, Pim
    De Wit, Leonore
    Weitz, Erica
    Andersson, Gerhard
    Huibers, Marcus J. H.
    JOURNAL OF EVIDENCE-BASED PSYCHOTHERAPIES, 2015, 15 (02): : 147 - 168
  • [37] Abandoning personalization to get to precision in the pharmacotherapy of depression
    Perlis, Roy H.
    WORLD PSYCHIATRY, 2016, 15 (03) : 228 - 235
  • [38] The monoamine theory of depression as a target to effective pharmacotherapy
    Karabin, Tomasz
    Biala, Grazyna
    Kruk-Slomka, Marta
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2023, 36 (02) : 108 - 113
  • [39] An Emotional Words fMRI Task Predicts Treatment Outcome with Standardized Pharmacotherapy for Depression
    Miller, Jeffrey M.
    Schneck, Noam
    Siegle, Greg J.
    Kikuchi, Toshiaki
    Oquendo, Maria A.
    Mann, J. John
    Parsey, Ramin V.
    BIOLOGICAL PSYCHIATRY, 2012, 71 (08) : 244S - 244S
  • [40] Can Cognitive Behavioral Therapy for Anxiety and Depression Be Improved with Pharmacotherapy? A Meta-analysis
    Tolin, David F.
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2017, 40 (04) : 715 - 738